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Extended Data Figure 1. Multiplexed imaging of human tuberculosis granulomas. (a) Hematoxylin and eosin 
stained serial sections of FOVs for MIBI-TOF imaging. (b) Multiplexed antibody panel grouped by marker category. (c) 
Grayscale images of endogenous ion signal and proteins in control tissues (tonsil, spleen, placenta). (d) Workflow for 
Deepcell-based segmentation of single cells from multiplexed images. (e) Histograms of non-zero signal for all proteins 
from single cell data. Blue line represents Gaussian smoothed density fit of histogram. Red line represents automatically 
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Extended Data Figure 2. Single cell phenotypic composition of human tuberculosis granulomas. (a) Conceptual 
overview of hierarchical FlowSOM algorithm application. (b) Heatmap of cell lineages clustered by mean normalized 
protein expression of markers shown along columns. (c) Cell phenotype maps for all FOVs. (d) Total cell counts across 
all FOVs sorted by descending order. (e) Major cell lineage composition across all FOVs. Bars represent the mean and 
standard error. (f) Major cell lineage frequency of total cells broken down by FOV. (g) Heatmap of Pearson correlation 
coefficients between all FOVs based on immune cell frequencies clustered by correlation coefficient with hierarchical 
clustering (distance = 1 – correlation, complete linkage). (h) Percent variance explained per clusters based on clustering 
in g. Real clustering output is plotted in teal, while grey shows the results for a randomized model of immune cell 
frequencies. (i) Chi-square analysis of pairwise cell prevalence. P-values were determined with a chi-square test 
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b IDO1 and PD-L1 positivity in resections by HIV status
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Extended Data Figure 3. Analysis of cellular features of therapeutic resections with respect to HIV status. (a) 
From left to right: CD4+ T: CD8+ T cell ratio represented as a log2 fold-change for each resection FOV, frequency of 
CD4+ T, CD8+ T cells, CD14+ monocytes, and 11b/c+ 206+ macrophages of total immune cells. Data is grouped and 
colored by HIV status (pink = HIV-, green = not reported, blue = HIV+). Line represents the median. (b) Frequency of 
IDO1+ or PD-L1+ cells (of total cells) across resection groups. Line represents the median. (c) ME frequency (of total 
cells) across resection groups. Line represents the median. All p-values determined with a Wilcoxon Rank Sum Test 
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ME Frequency FOV Clustering
Extended Data Figure 4. Spatial protein enrichment and microenvironment modeling of human tuberculosis 
granulomas. (a) Spatial enrichments of protein expression averaged across all TB granuloma FOVs and visualized as 
a heatmap hierarchically clustered (Euclidean distance, average linkage). Dashed boxes correspond to modules of 
protein enrichment corresponding to the myeloid core (green), lymphocytic cuff (blue), and a non-immune/other niche 
(pink). (b) Max probability maps (MaxPM) for all FOVs. (c) Representative hematoxylin & eosin and combined myeloid 
channel of a pleural TB FOV for identification of the myeloid core (left) and frequency of cells in the myeloid core across 
microenvironments (right). (d) Counts of cells broken down by phenotype across all FOVs and microenvironments. (e) 
Frequency of cells across microenvironments broken down by specimen type. (f) Percent variance explained per 
clusters based on clustering in Fig. 2f. (g) First two principal components of a principal component analysis (PCA) of 
all FOVs based on mean microenvironment probabilities. FOVs are colored by clusters from Fig. 1e and annotated by 
origin (therapeutic resection = dashed box, diagnostic biopsy = solid box). All boxplots represent the median and 
interquartile range. All p-values determined with a Wilcoxon Rank Sum Test where: ns p > 0.05, * p < 0.05, ** p < 0.01, 
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c Correlation between IDO1 and PD-L1 by cohort 
Cohort Pearson R p-value 
Pulmonary (all) 0.40 p < 2.2e-6
Extra-Pulmonary 0.64 p < 2.2e-6
Resection 0.22 p < 2.2e-6
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e PD-L1 or IDO1 as a function of cell subset and microenvironment
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Extended Data Figure 5. Immunoregulatory protein expression in TB granulomas. (a) Frequency of cells positive 
for IDO1 (top) or PD-L1 (bottom) broken down by FOV and cell phenotype. (b) Frequency of IDO1+ or PD-L1+ cells (of 
total cells) across specimen type (extrapulmonary biopsy = orange, pulmonary biopsy = blue, therapeutic resection = 
green). (c) Pearson correlation coefficient and p-value determined by t-test broken down by specimen type. (d) 
Frequency of neutrophils (left) and epithelial cells (right) positive for PD-L1 or IDO1 across all FOVs. (e) The frequency 
of IDO1+ and PD-L1+ myeloid cells for all myeloid cells subsets across ME. Any ME with fewer than 1% of the total cell 
subset is shaded gray. (f) Frequency of PD-1+ cells across all FOVs broken down by microenvironment. All boxplots 
represent the median and interquartile range. Unless otherwise specified all p-values were determined with a Wilcoxon 
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Extended Data Figure 6. Immunoregulatory protein expression in non-tuberculous granulomas and transcript 
expression in peripheral blood of TB patients. (a) Hematoxylin & eosin stained sections of sarcoidosis granuloma 
FOVs. (b) Frequency of immune cell subsets out of total immune cells broken down by sarcoidosis FOV. (c) 
Comparison of cell type frequency (out of total cells) between tuberculosis (dark green) and sarcoidosis (light green). 
(d) Shannon diversity index in tuberculosis and sarcoidosis FOVs. (e) Frequency of PD-L1+ cells across all sarcoidosis 
FOVs broken down by cell subset. (f) Representative immunohistochemistry images of PD-L1 or IDO1 (brown) of 
controls (top=spleen, bottom=placenta), a sarcoid granuloma, xanthoma granuloma, foreign body lesion, and 
endometrial lesion with hematoxylin nuclear counterstaining (purple).  (f) Hematoxylin and eosin (left) and MIBI-TOF 
staining for major cell lineage markers (middle) or IDO1 (magenta) and PD-L1 (cyan) (right) of a representative 
pulmonary Mycobacterium avium FOV. (h) Gene effect sizes in in latent TB (n = 173) versus healthy controls (n = 197), 
latent TB (n = 372) versus active TB (n = 479), and active TB (n = 168) versus end-of-treatment (n = 160). Bars 
represent the mean and standard deviation. Dashed red lines represent a relative effect size of 0.6. (i) PD-L2 gene 
expression across treatment time broken down by cure status (blue = definite cure and yellow = no cure). Line 
represents mean expression in each time point, connected across time points. P-value determined with Student’s T-
test for PD-L2 expression at d0 versus wk24 in the definite cure (DC, n = 71) and not-cured (NC, n =7) groups. All 
boxplots represent the median and interquartile range. Unless otherwise specified all p-values were determined with a 
Wilcoxon Rank Sum Test where: ns p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
 
 
 
 
  
